Breast Cancer Therapeutics Market trends research and projections for 2017-2024 - PowerPoint PPT Presentation


PPT – Breast Cancer Therapeutics Market trends research and projections for 2017-2024 PowerPoint presentation | free to download - id: 884ded-ZTAxM


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation

Breast Cancer Therapeutics Market trends research and projections for 2017-2024


Breast Cancer Therapeutics Market size was valued over USD 13 billion in 2016 and is expected to witness more than 9% CAGR from 2017 to 2024. Get more details @ – PowerPoint PPT presentation

Number of Views:13


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Breast Cancer Therapeutics Market trends research and projections for 2017-2024

Breast Cancer Therapeutics Market to surpass
28Bn by 2024 Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
Key Insights from Breast Cancer Therapeutics
  • U.S. breast cancer therapeutics market accounted
    for largest business share in 2016 and is
    anticipated to grow substantially over the
    forecast period. Increases access to breast
    cancer screening, diagnosis and treatment
    services will be the chief growth rendering
    factor. Moreover, increasing adoption of therapy
    drug by patients will fuel regional business
  • Rising incidence of disease due to increasing
    exposure to factors such as use of hormone
    replacement therapy (HRT), lifestyle related
    factors such as alcohol consumption, obesity and
    alteration in family size which stimulates the
    usage rate of therapeutics over the forecast
    period will propel the industry growth.
  • China should witness considerable growth in the
    coming years due to increase in awareness
    programs to spread alertness regarding breast
    cancer screening, robust economic growth and
    rising disposable income.

  • Brazil breast cancer therapeutics market is
    projected to grow at a significant CAGR over the
    forecast period. Increased life expectancy among
    individuals and healthcare facility development
    are the chief features driving breast cancer
    therapeutics market growth in the country.
  • Some of the companies operating in breast cancer
    therapeutics market are Roche Diagnostics,
    Pfizer, AstraZeneca, Novartis, Sanofi, Eisai, and
    Eli Lily. New product launches, strong product
    pipeline, geographical expansion, mergers and
    acquisition will mainly boost the business. Chief
    industry players will endeavor to strengthen
    their place in this competitive market by
    implementation these strategies.

U.S. Breast Cancer Therapeutics Market, By
Product, 2013 - 2024 (USD Billion)


Browse Full Market Research Report On
Bioreactor Market _at_ https// Request
for a Sample of this Research Report
_at_ https//
360 Analysis
  • Application Trends
  • Retail pharmacies held the largest market share
    in 2016 and will continue to be the biggest
    distribution channel for the industry over the
    forecast period. Growing shift from specialty to
    retail pharmacies owing to reimbursement
    variations and prolonged usage of oral
    formulations, particularly for targeted drug
    therapies will drive the business growth.
  • Regional Trends
  • U.S. breast cancer therapeutics market accounted
    for the highest regional share in 2016 due to
    growing prevalence of breast cancer and
    increasing RD funding through public and private
    sectors. Growing elderly population, breast
    feeding discontinuation at an early stage and
    increased access to cancer care will stimulate
    industry growth. Moreover, rising demand for
    tumor therapeutics will strongly drive industry
    growth in the country.
  • Competitive Market Share
  • Some of the major players in global breast cancer
    therapeutics market are AstraZeneca, Roche
    Diagnostics, Pfizer, Novartis, Eisai, Eli Lilly,
    Sanofi, and Celgene. Roche holds the largest
    market share owing to wide geographical presence
    and strong product portfolio. It is expected to
    dominate the industry revenue over the coming
    years. The company should face intense
    competition from other players such as
    AstraZeneca and Pfizer over the forecast years.

Stay In Touch Website Soci
al Media